News Daily News LV Mass Regression After TAVR Linked to Better Long-term Outcomes Michael O'Riordan May 13, 2020
News Conference News ACC 2020 New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals Michael O'Riordan April 06, 2020
News Conference News ACC 2020 Early Data Support TAVR in Bicuspid Valves, but Questions Remain Michael O'Riordan March 29, 2020
News Conference News ACC 2020 Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry Michael O'Riordan March 19, 2020
News Daily News Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge Michael O'Riordan March 17, 2020
News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Conference News CRT 2020 Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves Michael O'Riordan February 27, 2020
News Conference News CRT 2020 Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation Michael O'Riordan February 26, 2020
News Daily News MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR Michael O'Riordan February 13, 2020
News Daily News TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State Michael O'Riordan January 22, 2020
News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
News Daily News Long-term Watchman Data Reassure: CAP and CAP2 Registries Michael O'Riordan December 02, 2019
News Conference News PCR London Valves 2019 Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival Michael O'Riordan November 26, 2019
News Conference News PCR London Valves 2019 TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X Michael O'Riordan November 22, 2019
News Conference News PCR London Valves 2019 Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare Michael O'Riordan November 20, 2019
News Conference News PCR London Valves 2019 Signal of Impaired Sapien XT Durability in Midterm Follow-up Michael O'Riordan November 20, 2019
News Conference News PCR London Valves 2019 Two Small Series Support Role for Cerebral Protection in TAVR Michael O'Riordan November 18, 2019
News Daily News Sapien 3 Valve Approved in Europe for Low-Risk Patients Michael O'Riordan November 06, 2019
News Conference News TCT 2019 Predicting Final Valve Position After TAVR: Different Devices, Different Success Michael O'Riordan October 07, 2019